Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: no known allergies / adverse drug reactions attending: chief complaint: syncope major surgical or invasive procedure: : 1. aortic valve replacement with a 27-mm ultra aortic valve bioprosthesis, serial #. 2. coronary artery bypass grafting with reverse saphenous vein graft from aorta to distal right coronary artery. history of present illness: the patient is an 83-year-old gentleman referred to me by dr. for severe critical aortic stenosis and single-vessel coronary artery disease. the patient was admitted following aortic valve replacement and coronary artery bypass grafting. past medical history: aortic stenosis dyslipidemia hypertension coronary artery disease anemia tia primary open angle glaucoma bph osteoarthritis shoulder social history: -tobacco history: none -etoh: occasional -illicit drugs: none retired family history: no family history of premature cad physical exam: vs: general: 83 year-old male in no apparent distress. heent: normcephalic, mucus membranes moist neck: supple no lymphadenopathy card: rrr normal s1,s2 resp: decreased breath sounds otherwise clear gi: benign extr: warm 1+ edema incision: sternal and left lower extremity incision clean dry intact, no erythema neuro: awake, alert oriented pertinent results: wbc-14.4*# rbc-2.95* hgb-9.6* hct-28.3* mcv-96 mch-32.4* mchc-33.8 rdw-13.7 plt ct-100* wbc-14.4*# rbc-2.95* hgb-9.6* hct-28.3* mcv-96 mch-32.4* mchc-33.8 rdw-13.7 plt ct-100* wbc-8.4 rbc-2.81* hgb-9.2* hct-27.2* mcv-97 mch-32.8* mchc-33.9 rdw-14.0 plt ct-112* wbc-6.0 rbc-2.69* hgb-8.9* hct-26.1* mcv-97 mch-32.9* mchc-34.0 rdw-13.7 plt ct-82*# glucose-96 urean-19 creat-1.1 na-131* k-4.7 cl-99 hco3-23 glucose-99 urean-14 creat-1.0 na-133 k-4.4 cl-104 hco3-24 urean-15 creat-1.0 na-136 k-4.1 cl-109* hco3-23 cxr : tubes and catheters have been removed. allowing for low lung volumes, the mediastinal silhouette and vascularity are normal. there is no evidence of pneumothorax. minimal atelectasis is present at the left lung base. impression: minimal left basilar atelectasis, no evidence of pneumothorax. tte: prebypass the left atrium and right atrium are normal in cavity size. no spontaneous echo contrast or thrombus is seen in the body of the left atrium or left atrial appendage. left ventricular wall thicknesses and cavity size are normal. there is mild symmetric left ventricular hypertrophy. the left ventricular cavity is mildly dilated. overall left ventricular systolic function is normal (lvef>55%). right ventricular chamber size and free wall motion are normal. there are simple atheroma in the descending thoracic aorta. there are three aortic valve leaflets. the aortic valve leaflets are severely thickened/deformed. there is severe aortic valve stenosis (valve area 0.8-1.0cm2). severe (4+) aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. trivial mitral regurgitation is seen. there is no pericardial effusion. postbypass lv function now appears hyperdynamic. rv systolic function appears normal. there is a well seated, well functioning bioprosthesis in the aortic postion. no ai is visualized. the remaining study is unchanged from prebypass. brief hospital course: mr. was brought to the operating room on where he underwent aortic valve replacement with a 27-mm ultra aortic valve bioprosthesis, serial #. coronary artery bypass grafting with reverse saphenous vein graft from aorta to distal right coronary artery. please refer to operative report for further surgical details. overall the patient tolerated the procedure well and post-operatively was transferred to the cvicu intubated and sedated in stable but critical condition. he awoke neurologically intact and was extubated without incident. he weaned from pressor support, was hemodynamically stable. beta blocker/statin/aspirin and diuresis were initiated. he was gently diuresed toward the preoperative weight. pod#1 he was transferred to the telemetry floor for further recovery. lines and drains were discontinued per protocol without complication. his pacing wires were delayed being removed due to mild thrombocytopenia and his asa and aggrenox were held until his platlet count improved. mr. has a history of bph, his foley was discontinued on pod2 but he was unable to void. therefore the foley was repalaced and again discontinued 24hrs later afterwhich he successfully voided. the patient was evaluated by the physical therapy service for assistance with strength and mobility. by the time of discharge on pod #4 he was ambulating freely, the wound was healing and pain was controlled with oral analgesics. the patient was discharged to home with vna in good condition with appropriate follow up instructions advised. medications on admission: tamsulosin 0.4 mg qhs, finasteride 5 mg daily, multivitamin daily, fluticasone 50 mcg/actuation spray nasal , metoprolol succinate 50 mg daily, aggrenox 200-25 mg er , hydrochlorothiazide 50 mg daily, colestipol 1 gram daily, fish oil 1,000 mg daily, amlodipine 10 mg daily, lisinopril 40 mg daily, aspirin 81 mg daily, atorvastatin 40 mg daily discharge medications: 1. hydromorphone 2 mg tablet sig: 1-2 tablets po every 4-6 hours as needed for pain. disp:*50 tablet(s)* refills:*0* 2. dipyridamole-aspirin 200-25 mg cap, er multiphase 12 hr sig: one (1) cap po bid (2 times a day). disp:*60 * refills:*2* 3. atorvastatin 40 mg tablet sig: one (1) tablet po daily (daily). disp:*60 tablet(s)* refills:*2* 4. finasteride 5 mg tablet sig: one (1) tablet po daily (daily). disp:*60 tablet(s)* refills:*2* 5. tamsulosin 0.4 mg capsule, ext release 24 hr sig: one (1) capsule, ext release 24 hr po hs (at bedtime). disp:*60 capsule, ext release 24 hr(s)* refills:*2* 6. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day): while taking narcotics. disp:*60 capsule(s)* refills:*2* 7. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*60 tablet, delayed release (e.c.)(s)* refills:*2* 8. furosemide 20 mg tablet sig: one (1) tablet po once a day for 14 days. disp:*14 tablet(s)* refills:*0* 9. potassium chloride 10 meq tablet extended release sig: two (2) tablet extended release po once a day for 14 days. disp:*28 tablet extended release(s)* refills:*0* 10. ranitidine hcl 150 mg tablet sig: one (1) tablet po daily (daily). disp:*60 tablet(s)* refills:*2* 11. metoprolol tartrate 25 mg tablet sig: two (2) tablet po bid (2 times a day). disp:*120 tablet(s)* refills:*2* 12. lisinopril 5 mg tablet sig: one (1) tablet po daily (daily). disp:*60 tablet(s)* refills:*2* 13. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*60 tablet, delayed release (e.c.)(s)* refills:*2* discharge disposition: home with service facility: tba discharge diagnosis: aortic stenosis dyslipidemia hypertension coronary artery disease anemia tia primary open angle glaucoma bph osteoarthritis shoulder discharge condition: alert and oriented x3 nonfocal ambulating, gait steady sternal pain managed with oral analgesics sternal incision - healing well, no erythema or drainage discharge instructions: please shower daily including washing incisions gently with mild soap, no baths or swimming, and look at your incisions please no lotions, cream, powder, or ointments to incisions each morning you should weigh yourself and then in the evening take your temperature, these should be written down on the chart no driving for approximately one month and while taking narcotics, will be discussed at follow up appointment with surgeon when you will be able to drive no lifting more than 10 pounds for 10 weeks please call with any questions or concerns **please call cardiac surgery office with any questions or concerns . answering service will contact on call person during off hours** followup instructions: you are scheduled for the following appointments: wound check at cardiac surgery office surgeon dr. date/time: 2:45 in the building cardiologist dr. please call to schedule the following: primary care dr. in weeks **please call cardiac surgery office with any questions or concerns . answering service will contact on call person during off hours** procedure: extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of one coronary artery open and other replacement of aortic valve with tissue graft diagnoses: coronary atherosclerosis of native coronary artery pure hypercholesterolemia unspecified essential hypertension aortic valve disorders hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other and unspecified angina pectoris unspecified late effects of cerebrovascular disease osteoarthrosis, unspecified whether generalized or localized, shoulder region other secondary thrombocytopenia 

Answer: The patient is high likely exposed to